Immunity£ºÄÉÃ׿ÅÁ£¿¹Ô»î»¯³õʼCD4Tϸ°ûлúÖÆ
²»Í¬¿¹Ô»î»¯CD4Tϸ°û¼°²ÎÓëGC·´Ó¦µÄ»úÖÆ
Ê÷ͻ״ϸ°ûÒ»Ö±±»ÈÏΪÊÇÌåÄÚΨһÄܹ»½«¿¹ÔÌá³Ê¸ø³õʼ״̬CD4 Tϸ°ûµÄ¿¹ÔÌá³Êϸ°û¡£Bϸ°ûºÍ¾ÞÊÉϸ°ûËäÒ²ÄÜÌá³Ê¿¹Ô£¬µ«ËüÃÇÖ»ÄܻЧӦTϸ°û»òÕß¼ÇÒäTϸ°û¡£Ô½À´Ô½¶àµÄÖ¤¾Ý°µÊ¾ÁËÔÚijЩÌõ¼þÏÂÊ÷ͻ״ϸ°û¶ÔÓÚ³õʼ״̬µÄCD4 Tϸ°ûµÄ»î»¯²¢²»ÊDZØÐèµÄ£¬ÄÇÌåÄÚ»¹ÓÐÄÄЩ¿¹ÔÌá³Êϸ°ûÄܹ»»î»¯³õʼ״̬CD4 Tϸ°ûÄØ£¿
ÖпÆÔºÉúÎïÎïÀíÑо¿ËùÓëÉϺ£°Í˹µÂËùµÄÑо¿ÈËÔ±·¢±íÁËÌâΪ¡°B cells are the dominant antigen-presenting cells that activate naive CD4+ T cells upon immunization with a virus-derived nanoparticle antigen¡±µÄÎÄÕ£¬·¢ÏÖÁËÄÉÃ׿ÅÁ£¿¹Ô»î»¯CD4 Tϸ°ûµÄлúÖÆ¡£
Ñо¿ÈËÔ±ÀûÓÃʵÑéÊÒËùÌØÓеÄQ¦Â²¡¶¾Ñù¿ÅÁ£ÏµÍ³£¬Ñо¿ÁËÔÚ²¡¶¾Ñù¿ÅÁ£¸ÐȾ¹ý³ÌÖУ¬Õë¶ÔÕâÖÖ¿ÅÁ£¿¹ÔµÄÌØÒìÐÔCD4 Tϸ°ûµÄ»î»¯¹ý³Ì¡£
ËûÃÇ·¢ÏÖ¿¹ÔÌØÒìÐÔµÄBϸ°ûÄܹ»¿ìËÙÉãÈ¡¿¹Ô£¬È»ºóÖ±½Ó»î»¯³õʼ״̬CD4 Tϸ°û£¬²¢ÇÒÕâÒ»¹ý³Ì²¢²»ÒÀÀµÓÚDCsϸ°û£¬Í¬Ê±»¹·¢ÏÖBϸ°û±í´ïµÄTLRÐźŶÔCD4 Tϸ°ûµÄ»î»¯ºÍ·Ö»¯·¢»Ó׏ؼü×÷Óá£
ÕâÏîÑо¿Ö¤Ã÷ÁË¿¹ÔÌØÒìÐÔµÄBϸ°û¿ÉÒԻ³õʼ״̬CD4 Tϸ°û£¬¸Ä±äÁËÔÓеĹÛÄî:ÌåÄÚÖ»ÓÐDCs¿ÉÒԻ³õʼ״̬CD4 Tϸ°û£¬¶Ô¿¹²¡¶¾¹ý³ÌµÄCD4 Tϸ°û·´Ó¦ÓÐÁËеÄÈÏʶ¡£¸Ã·¢ÏÖ½«°ïÖúÎÒÃÇÀí½âBϸ°ûÔÚ¿¹¸ÐȾÃâÒߺÍ×ÔÉíÃâÒßÖз¢»Ó×÷ÓõĻúÖÆ¡£¶ÔδÀ´·¢Õ¹ÐÂÐÍÒßÃçºÍÃâÒßÖÎÁÆÊֶι©Ð°еãºÍÀíÂÛÖ¸µ¼¡£
ÕâÏ×÷ÓÉÖйú¿ÆÑ§ÔºÉúÎïÎïÀíÑо¿Ëùºî°Ù¶«¿ÎÌâ×éÓëÖпÆÔºÉϺ£°Í˹µÂËùÌÆºê¿ÎÌâ×éºÏ×÷Íê³É¡£ÎÒËùºî°Ù¶«Ñо¿Ô±£¬»ªÕ×ÁÕ¸±Ñо¿Ô±ÒÔ¼°ÖпÆÔºÉϺ£°Í˹µÂËùÌÆºêÑо¿Ô±Îª±¾ÎĵĹ²Í¬Í¨Ñ¶×÷Õߣ¬ºî°Ù¶«¿ÎÌâ×éµÄÖúÀíÑо¿Ô±ºéʤΪ±¾ÎĵĵÚÒ»×÷Õß¡£¹¤×÷»ñµÃÉúÎïÎïÀíËùÖì±ù¿ÎÌâ×飬SportËùÕŸ£Æ¼¿ÎÌâ×éÒÔ¼°ÖÜÐñÓî¿ÎÌâ×飬±±¾©´óѧҽѧԺ¸ðÇà¿ÎÌâ×éµÄºÏ×÷ºÍÖ§³Ö¡£¸ÃÑо¿µÃµ½¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίºÍÖйú¿ÆÑ§ÔºµÄÏîĿ֧³Ö¡£
ÔÎıêÌ⣺
B cells are the dominant antigen-presenting cells that activate naive CD4+ T cells upon immunization with a virus-derived nanoparticle antigen
https://www.cell.com/immunity/fulltext/S1074-7613(18)30353-4